Corrigendum to ‘The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010–20’ [International Journal of Infectious Diseases 105 (April 2021) 91–104]
Atieh Darbandi,
Arezoo Asadi,
Roya Ghanavati,
Roghayeh Afifirad,
Amir Darb Emamie,
Maryam Kakanj,
Malihe Talebi
Affiliations
Atieh Darbandi
Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Tehran, Iran; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Arezoo Asadi
Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Tehran, Iran; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Roya Ghanavati
Behbahan Faculty of Medical Sciences, Behbahan, Iran
Roghayeh Afifirad
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Amir Darb Emamie
Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Maryam Kakanj
Food and Drug Laboratory Research Center, Food and Drug Administration, MOH&ME, Tehran, Iran; Maryam Kakanj, Food and Drug Laboratory Research Center, Food and Drug Administation, MOH&ME, Tehran, Iran.
Malihe Talebi
Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Tehran, Iran; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Corresponding authors: Malihe Talebi, Department of Microbiology, School of Medicine and Microbial Biotechnology Research Centre, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran, Iran.
